A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...

As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...

Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...

President Trump has placed an indefinite suspension on research grant reviews and travel at the National Institutes of Health ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

A trio of Democrats on Monday called on the Trump administration to restore full operations at the National Institutes of ...

Cancellations of NIH grant review panels, in particular, could affect cancer research grants and funding. In these NIH grant ...

Scientists at the National Institutes of Health have been told the communications pause announced by the Trump Administration ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...

Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up ...

Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...